| Incidence and clinical course of lercanidipine-associated cloudy effluent in continuous ambulatory peritoneal dialysis. | |
| | |
MedLine Citation:
|
PMID: 20860906 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Lercanidipine, a novel dihydropyridine calcium channel antagonist, has been reported to cause sterile cloudy effluent in patients on continuous ambulatory peritoneal dialysis (CAPD). The purpose of the study was to evaluate the incidence and clinical course of cloudy effluent associated with lercanidipine in uremic patients on CAPD. METHODS: We designed a consecutive observation study in 40 non-diabetic uremic patients on CAPD treated with lercanidipine 5 mg daily. Lercanidipine-induced cloudy effluent was defined as acellular and culture-negative effluent associated with the use of this drug and exclusion of other causative factors. Time to develop cloudy effluent, dwell effluent amount and the associated symptoms were recorded. Baseline peritoneal membrane characteristics, net ultrafiltration per session and routine biochemistry in serum and dialysate were compared between patients with and without the development of cloudy effluent. RESULTS: 9 patients (22.5%) developed cloudy effluent within 2 days of lercanidipine initiation. The triglyceride concentration in cloudy effluent was greater than 10 mg/dl (19.3 ± 6.3 mg/dl). There was a significant increase in dwell effluent amount (93.3 ± 64 ml/exchange, p < 0.05). Clinical symptoms as abdominal cramping or fullness were observed in 3 patients. All cloudy effluent disappeared after ceasing lercanidipine but recurred after resumption of lercanidipine. Baseline dialysate to plasma (D/P) creatinine ratio (0.7 ± 0.1 vs. 0.51 ± 0.1; p = 0.07) tended to be higher and dialysate total protein (93.4 ± 33 vs. 61.5 ± 24 mg/dl; p < 0.05) were significantly higher in patients with than without the development of cloudy effluent. CONCLUSION: The incidence of lercanidipine-associated cloudy effluent is relatively higher with transient benign clinical symptoms. Patients with lercanidipine associated cloudy effluent tend to have a higher membrane transport with an increased effluent amount. |
| | |
Authors:
|
P-J Hsiao; H-W Lin; C-C Sung; C-W Wang; P Chu; S-H Lin |
Related Documents
:
|
686046 - The emotional and psychosexual aspects of hysterectomy. 9203046 - Continuous ambulatory peritoneal dialysis. experience in a single renal unit in the uk. 6429846 - The dialysis catheter and infectious peritonitis in intermittent peritoneal dialysis. 8893116 - Disposition of foscarnet during peritoneal dialysis. 19630486 - Percutaneous nephrolithotomy in the prone and prone-flexed positions: anatomic consider... 21345536 - Usefulness of cholestanol levels in the diagnosis and follow-up of patients with cerebr... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical nephrology Volume: 74 ISSN: 0301-0430 ISO Abbreviation: Clin. Nephrol. Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-09-23 Completed Date: 2010-11-02 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0364441 Medline TA: Clin Nephrol Country: Germany |
Other Details:
|
Languages: eng Pagination: 217-22 Citation Subset: IM |
Affiliation:
|
Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Calcium Channel Blockers / pharmacology* Dialysis Solutions / metabolism* Dihydropyridines / pharmacology* Female Humans Male Middle Aged Nephelometry and Turbidimetry Peritoneal Dialysis, Continuous Ambulatory* Statistics, Nonparametric |
| Chemical | |
Reg. No./Substance:
|
0/Calcium Channel Blockers; 0/Dialysis Solutions; 0/Dihydropyridines; 100427-26-7/lercanidipine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Clinical impact of a combined therapy of peritoneal dialysis and hemodialysis.
Next Document: Intra-abdominal hypertension can be monitored with femoral vein catheters during CRRT and may cause ...